MedPath

Lacellate Solution - 250

Lacellate Solution - 250

Approved
Approval ID

6fbfe1f7-3db1-4c9f-aafb-d336a563c9c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2022

Manufacturers
FDA

IT3 Medical LLC

DUNS: 079971231

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium chloride, potassium chloride, sodium lactate and calcium chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70529-025
Application NumberNDA016682
Product Classification
M
Marketing Category
C73594
G
Generic Name
Sodium chloride, potassium chloride, sodium lactate and calcium chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 6, 2018
FDA Product Classification

INGREDIENTS (5)

SODIUM LACTATEActive
Quantity: 310 mg in 100 mL
Code: TU7HW0W0QT
Classification: ACTIB
SODIUM CHLORIDEActive
Quantity: 600 mg in 100 mL
Code: 451W47IQ8X
Classification: ACTIB
POTASSIUM CHLORIDEActive
Quantity: 30 mg in 100 mL
Code: 660YQ98I10
Classification: ACTIM
CALCIUM CHLORIDEActive
Quantity: 20 mg in 100 mL
Code: M4I0D6VV5M
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lacellate Solution - 250 - FDA Drug Approval Details